{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:58:45Z","timestamp":1768535925216,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25781-8","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:54:18Z","timestamp":1764910458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional epidemiological study of hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners"],"prefix":"10.1186","volume":"26","author":[{"given":"Hery Djagat","family":"Purnomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Farhanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Oktaria","family":"Permatadewi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Retty Kharisma","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesti Triwahyu","family":"Hutami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didik","family":"Indiarso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muji","family":"Rahayu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Triwardhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adhi","family":"Yustiawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabowo Budi","family":"Irianto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce J.","family":"Maya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhewi","family":"Sukowati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mochamad Abdul","family":"Hakam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muchlis AU","family":"Sofro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"25781_CR1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Geneva: WHO; 2021."},{"key":"25781_CR2","unstructured":"Munira SL. Survei Kesehatan Indonesia (SKI) 2023. Jakarta: Kementerian Kesehatan Republik Indonesia; 2023. https:\/\/kemnkes.go.id\/app_asset\/file_content_donwload\/17169067256655eae5553985.98376730.pdf."},{"key":"25781_CR3","unstructured":"World Health Organization. Hepatitis C [Internet]. Geneva: World Health Organization; 2025 Jul 25 [cited 2025 October 28]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"25781_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","volume":"4","author":"GS Cooke","year":"2019","unstructured":"Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & hepatology commission. The Lancet Gastroenterology & Hepatology. 2019;4:135\u201384.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"25781_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41575-020-0332-6","volume":"17","author":"AL Cox","year":"2020","unstructured":"Cox AL, El-Sayed MH, Kao J-H, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17:533\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"25781_CR6","unstructured":"World Health Organization. Elimination of hepatitis by 2030. Geneva: WHO; [cited 2025 October 28]. Available from: https:\/\/www.who.int\/health-topics\/hepatitis\/elimination-of-hepatitis-by-2030."},{"key":"25781_CR7","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: WHO; 2024 [cited\u202f2025 October 28]. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/6b18ac34-f56a-466e-9660-b5653cb52ef0\/content."},{"key":"25781_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1515\/jtim-2017-0017","volume":"5","author":"D Crowley","year":"2017","unstructured":"Crowley D, Cullen W, Laird E, et al. Exploring patient characteristics and barriers to hepatitis C treatment in patients on opioid substitution treatment attending a community based fibro-scanning clinic. J Transl Intern Med. 2017;5:112\u20139.","journal-title":"J Transl Intern Med"},{"key":"25781_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/NEJMp1311941","volume":"370","author":"JD Rich","year":"2014","unstructured":"Rich JD, Allen SA, Williams BA. Responding to hepatitis C through the criminal justice system. N Engl J Med. 2014;370:1871\u20134.","journal-title":"N Engl J Med"},{"key":"25781_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/hep.26387","volume":"58","author":"S Larney","year":"2013","unstructured":"Larney S, Kopinski H, Beckwith CG, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58:1215\u201324.","journal-title":"Hepatology"},{"key":"25781_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.drugpo.2018.06.017","volume":"59","author":"E Pontali","year":"2018","unstructured":"Pontali E, Fiore V, Ialungo AM, et al. Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy. Int J Drug Policy. 2018;59:50\u20133.","journal-title":"Int J Drug Policy"},{"key":"#cr-split#-25781_CR12.1","unstructured":"Department of Health, Government of Punjab. Revised PC-I Comprehensive TB Control Programme, Punjab 2015\/16-2017\/18 [Internet]. Lahore: Department of Health, Government of Punjab"},{"key":"#cr-split#-25781_CR12.2","unstructured":"2017 [cited 2025 October 28]. Available from: https:\/\/phkh.nhsrc.pk\/sites\/default\/files\/2019-06\/PC-1%20Comprehensive%20TB%20Control%20Programme%20Punjab%202015_16%202017_18.pdf."},{"key":"25781_CR13","doi-asserted-by":"crossref","unstructured":"Wali A, Khan D, Safdar N, et al. Prevalence of tuberculosis, HIV\/AIDS, and hepatitis in a prison of Balochistan: a cross-sectional survey. BMC Public Health. 2019;19:1631.","DOI":"10.1186\/s12889-019-8011-7"},{"key":"25781_CR14","first-page":"476","volume":"60","author":"ZA Gorar","year":"2010","unstructured":"Gorar ZA, Zulfikar I. Seropositivity of hepatitis C in prison inmates of Pakistan\u2013a cross sectional study in prisons of Sindh. J Pak Med Assoc. 2010;60:476\u20139.","journal-title":"J Pak Med Assoc"},{"key":"25781_CR15","unstructured":"World Health Organization, United Nations Office on Drugs and Crime. Prisons and Health. Edited by Stefan Enggist, Lars M\u00f8ller, Gauden Galea & Caroline Udesen [Internet]. Geneva: WHO & UNODC; 2014 [cited 2025 October 28]. Available from: https:\/\/www.unodc.org\/documents\/hiv-aids\/publications\/Prisons_and_other_closed_settings\/2014_WHO_UNODC_Prisons_and_Health_eng.pdf."},{"key":"25781_CR16","unstructured":"World Health Organization, United Nations Office on Drugs and Crime. Health in Prisons in the WHO European Region [Internet]. Geneva: WHO & UNODC; n.d. [cited\u202f2025 October 28]. Available from: https:\/\/www.unodc.org\/documents\/justice-and-prison-reform\/WHO_Europe.pdf."},{"key":"25781_CR17","unstructured":"United States Department of State. 2016 Country Reports on Human Rights Practices \u2014 Pakistan [Internet]. Washington, DC: U.S. Department of State, Bureau of Democracy, Human Rights and Labor; 2017 [cited\u202f2025 October 28]. Available from: http:\/\/www.state.gov\/j\/drl\/rls\/hrrpt\/humanrightsreport\/index.htm?year=2016&dlid=265546."},{"key":"25781_CR18","first-page":"155","volume":"56","author":"J Kurniawan","year":"2024","unstructured":"Kurniawan J, Aprilicia G, Purnomo HD, et al. Factors associated with hepatitis B and hepatitis C among infected patients in Indonesia and their knowledge and attitude: A multicenter observational study. Acta Med Indones. 2024;56:155\u201367.","journal-title":"Acta Med Indones"},{"key":"25781_CR19","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/ajt.16661","volume":"22","author":"MK Weng","year":"2022","unstructured":"Weng MK, Doshani M, Khan MA, et al. Universal hepatitis B vaccination in adults aged 19\u201359 years: updated recommendations of the advisory committee on immunization practices\u2014United States, 2022. Am J Transplant. 2022;22:1714\u201320.","journal-title":"Am J Transplant"},{"key":"25781_CR20","first-page":"1","volume":"0","author":"AG Farghaly","year":"2020","unstructured":"Farghaly AG, Alkassabany YM, El- EM, HBV. HCV and HIV among female sex workers ; is it a health problem ? Sex Relatsh Therapy. 2020;0:1\u201316.","journal-title":"Sex Relatsh Therapy"},{"key":"25781_CR21","unstructured":"Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Hepatitis\u202fC. Keputusan Menteri Kesehatan No.\u202fHK.01.07\/MENKES\/681\/2019; 2019 [cited 2025 October 28]. Available from: https:\/\/kemkes.go.id\/app_asset\/file_content_download\/1700729233655f119184d6d5.26384457.pdf."},{"key":"25781_CR22","doi-asserted-by":"crossref","unstructured":"Karimi SE, Bayani A, Higgs P, et al. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and meta-analysis. Substance Abuse Treatment, Prevention, and Policy. 2020;15(1):64.","DOI":"10.1186\/s13011-020-00306-1"},{"key":"25781_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4274\/vhd.35220","volume":"21","author":"\u00d6 AYDEM\u0130R","year":"2015","unstructured":"AYDEM\u0130R \u00d6, DEM\u0130RAY T, K\u00d6RO\u011eLU M, et al. Hepatitis c prevalence in different age groups; people over 50 years of age may receive one-time testing for anti-HCV. Viral Hepatit Dergisi. 2015;21:40\u20133.","journal-title":"Viral Hepatit Dergisi"},{"key":"25781_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10620-006-3139-6","volume":"51","author":"\u00c7 Karaca","year":"2006","unstructured":"Karaca \u00c7, \u00c7akalo\u011flu Y, Demir K, et al. Risk factors for the transmission of hepatitis c virus infection in the Turkish population. Dig Dis Sci. 2006;51:365\u20139.","journal-title":"Dig Dis Sci"},{"key":"25781_CR25","doi-asserted-by":"crossref","unstructured":"Noreen A, Adnan F, Alam N. et al. Prevalence and Associated Risk Factors Analysis of Hepatitis B & C Infections in the Low Socioeconomic Communities; A Cross Sectional Study from Pakistan. Research Square [Preprint]. 2021.","DOI":"10.21203\/rs.3.rs-67644\/v1"},{"key":"25781_CR26","first-page":"1390","volume":"22","author":"AM Akhtar","year":"2015","unstructured":"Akhtar AM, Majeed S, Jamil M, et al. Prevalence of hepatitis C infection; general patients attending various hospitals of Lahore, Pakistan: a cross sectional study. Prof Med J. 2015;22:1390\u20136.","journal-title":"Prof Med J"},{"key":"25781_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4269\/ajtmh.20-1595","volume":"105","author":"TP Merati","year":"2021","unstructured":"Merati TP, Karyana M, Tjitra E, et al. Prevalence of HIV infection and resistance mutations in patients hospitalized for febrile illness in Indonesia. Am J Trop Med Hyg. 2021;105:960\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"25781_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3329\/dujs.v71i2.69125","volume":"71","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury S, Akter NJ, Rahman MS, et al. A systematic review and meta-analysis of injecting drug use as a risk factor of HIV in Bangladesh. Dhaka Univ J Sci. 2023;71:160\u20138.","journal-title":"Dhaka Univ J Sci"},{"key":"25781_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1353\/hpu.2014.0039","volume":"25","author":"AD Fox","year":"2014","unstructured":"Fox AD, Anderson MR, Bartlett G, et al. A description of an urban transitions clinic serving formerly incarcerated people. J Health Care Poor Underserved. 2014;25:376\u201382.","journal-title":"J Health Care Poor Underserved"},{"key":"25781_CR30","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.2105\/AJPH.2015.302635","volume":"105","author":"PA Iroh","year":"2015","unstructured":"Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105:e5-16.","journal-title":"Am J Public Health"},{"key":"25781_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/cid\/cir446","volume":"53","author":"SA Springer","year":"2011","unstructured":"Springer SA, Spaulding AC, Meyer JP, et al. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53:469\u201379.","journal-title":"Clin Infect Dis"},{"key":"25781_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1478-3231.2011.02706.x","volume":"32","author":"CE McGowan","year":"2012","unstructured":"McGowan CE, Fried MW. Barriers to hepatitis C\u2009treatment. Liver Int. 2012;32:151\u20136.","journal-title":"Liver Int"},{"key":"25781_CR33","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","volume":"7","author":"R Zampino","year":"2015","unstructured":"Zampino R. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7:2323.","journal-title":"World J Hepatol"},{"key":"25781_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/jwh.2009.1469","volume":"19","author":"AE Nijhawan","year":"2010","unstructured":"Nijhawan AE, Salloway R, Nunn AS, et al. Preventive healthcare for underserved women: results of a prison survey. J Womens Health. 2010;19:17\u201322.","journal-title":"J Womens Health"},{"key":"25781_CR35","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1365-3156.2010.02655.x","volume":"15","author":"EJ Nelwan","year":"2010","unstructured":"Nelwan EJ, Van Crevel R, Alisjahbana B, et al. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Tropical Med Int Health. 2010;15:1491\u20138.","journal-title":"Tropical Med Int Health"},{"key":"25781_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0038-1666841","volume":"38","author":"J Lazarus","year":"2018","unstructured":"Lazarus J, Safreed-Harmon K, Thursz M, et al. The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations. Semin Liver Dis. 2018;38:181\u201392.","journal-title":"Semin Liver Dis"},{"key":"25781_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.26623","volume":"59","author":"M Hellard","year":"2014","unstructured":"Hellard M, Doyle JS, Sacks-Davis R, et al. Eradication of hepatitis C infection: the importance of targeting people who inject drugs. Hepatology. 2014;59:366\u20139.","journal-title":"Hepatology"},{"key":"25781_CR38","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","volume":"113","author":"A Cuadrado","year":"2018","unstructured":"Cuadrado A, Llerena S, Cobo C, et al. Microenvironment eradication of hepatitis C: a novel treatment paradigm. Am J Gastroenterol. 2018;113:1639\u201348.","journal-title":"Am J Gastroenterol"},{"key":"25781_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/cid\/cis1202","volume":"56","author":"AR Lloyd","year":"2013","unstructured":"Lloyd AR, Clegg J, Lange J, et al. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis. 2013;56:1078\u201384.","journal-title":"Clin Infect Dis"},{"key":"25781_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12916-015-0440-2","volume":"13","author":"N Scott","year":"2015","unstructured":"Scott N, McBryde E, Vickerman P, et al. The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments. BMC Med. 2015;13:198.","journal-title":"BMC Med"},{"key":"25781_CR41","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/add.13783","volume":"112","author":"J Stone","year":"2017","unstructured":"Stone J, Martin NK, Hickman M, et al. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Addiction. 2017;112:1302\u201314.","journal-title":"Addiction"},{"key":"25781_CR42","unstructured":"Squa St\u00f6ver H, Weilandt C, Zurhold H, et al. Final report on prevention, treatment, and harm reduction services in prison, on reintegration services on release from prison and methods to monitor\/analyse drug use among prisoners. European Commission, Directorate General for Health and Consumers, Drug Policy & Harm Reduction; 2008. (SANCO\/2006\/C4\/02). Available from: http:\/\/ec.europa.eu\/health\/ph_determinants\/life_style\/drug\/documents\/drug_frep1.pdfre. [Preprint]. 2021 ."},{"key":"25781_CR43","doi-asserted-by":"publisher","first-page":"e90560","DOI":"10.1371\/journal.pone.0090560","volume":"9","author":"A Marco","year":"2014","unstructured":"Marco A, Gallego C, Cayl\u00e0 JA. Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period. PLoS One. 2014;9:e90560.","journal-title":"PLoS One"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25781-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25781-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25781-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:03:31Z","timestamp":1768266211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25781-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25781"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25781-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by Health Research Ethics Committee of Dr. Kariadi Hospital, Semarang, Indonesia (No. 995\/EC\/KEPK-RSDK\/2022). Written informed consent was obtained from all screened participants after explanation that their participation in the survey would not affect their imprisonment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No identifying images or personal details of participants are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}